Ranbaxy Laboratories Ltd. Company Profile

16:58 EDT 29th August 2015 | BioPortfolio

Ranbaxy Laboratories Limited, India's largest pharmaceutical company, is an integrated, research based, international pharmaceutical company producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. Ranbaxy’s continued focus on R&D has resulted in several approvals, in developed and emerging markets many of which incorporate proprietary Novel Drug Delivery Systems (NDDS) and technologies, developed at its own labs. The company has further strengthened its focus on generics research and is increasingly working on more complex and specialty areas. Ranbaxy serves its customers in over 125 countries and has an expanding international portfolio of affiliates, joint ventures and alliances, ground operations in 46 countries and manufacturing operations in 7 countries. Ranbaxy is a member of the Daiichi Sankyo Group. Through strategic in-licensing opportunities and its hybrid business model with Daiichi Sankyo, a leading global pharma innovator headquartered in Tokyo, Japan, Ranbaxy is introducing many innovator products in markets around the world, where it has a strong presence. This is in line with the company’s commitment to increase penetration and improve access to medicines, across the globe. For more information, please visit www.ranbaxy.com.


News Articles [272 Associated News Articles listed on BioPortfolio]

Sun Pharma finally completes Ranbaxy acquisition

Indian generic drugmaker Sun Pharmaceutical Industries has at last completed the merger of Ranbaxy Laboratories…

U.S. class action asserts India's Ranbaxy manipulated FDA rules

MUMBAI (Reuters) - Indian generic drugmaker Ranbaxy Laboratories Ltd has been sued in a district court in the United States for allegedly manipulating U.S. Food and Drug Administration rules for years...

India's Sun Pharma misses profit estimates on Ranbaxy costs

MUMBAI, May 29 (Reuters) - Sun Pharmaceutical Industries Ltd , India's largest drugmaker by sales, reported fourth-quarter profit well below analysts' expectations, hit by costs related to integrating...

India's Sun Pharma open to large acquisitions post Ranbaxy deal

MUMBAI, March 25 (Reuters) - Sun Pharmaceutical Industries Ltd, India's largest drugmaker by sales, said on Wednesday its $3.2 billion acquisition of smaller rival Ranbaxy Laboratories Ltd will not re...

India's Sun Pharma expects Ranbaxy costs to hit 2016 revenue

MUMBAI, July 20 (Reuters) - Sun Pharmaceutical Industries Ltd, India's largest drugmaker by sales, said on Monday its fiscal 2016 revenue might decline or stay flat due to costs related to fixing manu...

With Ranbaxy Under Belt, Sun Eyes Fast Track Global Growth

Sun and Ranbaxy have finally combined into a single global company, but that could be just the beginning of a series of fresh challenges. Sun said it will look at growing its businesses faster than th...

U.S. judge denies Ranbaxy bid to reinstate approvals for Valcyte, Nexium copies

MUMBAI (Reuters) - A U.S. federal judge has denied Indian generic drugmaker Ranbaxy Laboratories Ltd's bid to reinstate approvals granted to it to launch the first copies of the heartburn drug Nexium ...

Ranbaxy fails to reverse FDA decision over Valcyte and Nexium

Indian generics company Ranbaxy has yet again failed in its bid to become the first company in the US to sell generic versions of the AstraZeneca blockbuster acid-reflux drug Nexium (esomeprazole) and...

Drugs and Medications [431 Associated Drugs and Medications listed on BioPortfolio]

Desquam-x wash [Ranbaxy Laboratories Inc.]

DRUG FACTS

Famotidine [Ipca Laboratories Limited]

Famotidine Tablets USP

Cetirizine hydrochloride [Ipca Laboratories Limited]

Cetirizine Hydrochloride Tablets 10 mg

Clindamycin hydrochloride [RedPharm Drug Inc.]

Eurax [Ranbaxy Laboratories Inc.]

Eurax (crotamiton USP)Lotion/Cream (10% w/w)FOR TOPICAL USE ONLYNOT FOR OPHTHALMIC, ORAL, OR INTRAVAGINAL USERx only

PubMed Articles [184 Associated PubMed Articles listed on BioPortfolio]

Practices for Identifying and Rejecting Hemolyzed Specimens Are Highly Variable in Clinical Laboratories.

Context .- Hemolysis is an important clinical laboratory quality attribute that influences result reliability. Objective .- To determine hemolysis identification and rejection practices occurring in c...

Critical Value Reporting at Egyptian Laboratories.

To examine critical value reporting policies and practices and to identify critical value ranges for selected common laboratory assays at inpatient division of laboratories of Alexandria hospitals.

Proficiency monitoring of monoclonal antibody cocktail-based enzyme-linked immunosorbent assay for detection of allergen-specific immunoglobulin E in dogs.

The purpose of our study was to document the continued comparative proficiency of different laboratories that perform a monoclonal antibody-based enzyme-linked immunosorbent assay (macELISA) for detec...

Investigation of laboratory testing issues in the context of the Salmonella National Control Programme in Great Britain.

1. The objective of this study was to identify any issues arising during the laboratory testing of samples collected under the National Control Programme for Salmonella. 2. A questionnaire-based surve...

Perception of health and safety risks among workers pathology laboratories.

Health care workers are experiencing increasing numbers of occupational illnesses. Safety practices in anatomical pathology laboratories (APL) are crucial to prevent unnecessary exposures to both chem...

Clinical Trials [191 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Clarithromycin 250 mg/5 mL Powder for Oral Suspension Under Fasting Conditions

To compare the single-dose oral bioavailability of clarithromycin 250-mg/5 mL powder for oral suspension of Ranbaxy Laboratories with that of Abbott Laboratories (Biaxin®) following admin...

Bioequivalence Study of Quinapril Hydrochloride 20 mg and Hydrochlorothiazide 25 mg Tablets Under Fed Conditions

This open-label, balanced, randomized, two-treatment, four-period, two-sequence, single dose, crossover fully replicated study was conducted on fixed-dose combination of quinapril 20 mg an...

Bioequivalence Study of Carvedilol 12.5mg Tablets Under Fed Conditions

The objective of this study was to compare the single-dose oral bioavailability of Carvedilol 12.5 mg tablets of Ranbaxy Laboratories with Coreg 12.5 mg tablets of Glaxosmithkline in healt...

Bioequivalence Study of Glimepiride 1mg Tablets Under Fed Conditions

The objective of this study is to compare the relative bioavailability of glimepiride 1 mg tablets (manufactured by Ranbaxy Laboratories Limited) with that of AMARYL® 1 mg tablets (follow...

Bioequivalence Study of Hydrochlorothiazide 50mg Tablets Under Fasting Conditions

To compare the single-dose oral bioavailability of hydrochlorothiazide 50 mg tablet of Ohm Laboratories (A subsidiary of Ranbaxy pharmaceuticals USA) with hydrochlorothiazide 50 mg tablet ...

Companies [906 Associated Companies listed on BioPortfolio]

Ranbaxy Pharmaceuticals Inc.

Ranbaxy Pharmaceuticals Inc. (RPI) based in Jacksonville, Florida USA, is a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), India’s largest pharmaceutical comp...

Ranbaxy Laboratories Ltd.

Ranbaxy Laboratories Limited, India's largest pharmaceutical company, is an integrated, research based, international pharmaceutical company producing a wide range of quality, aff...

Ranbaxy Laboratories Limited

Ranbaxy Laboratories Limited, India's largest pharmaceutical company, headquartered in India, is an integrated, research based, international pharmaceutical company, producing a wide range of quality,...

Sterling Rasayan (P) Ltd

In less than twenty years, Sterling through its professional approach and innovative marketing strategy has been able to cater to the requirements of many prestigious customers from local producers t...

KENT LABORATORIES

Since 1974 KENT LABORATORIES has been a specialist in the production of polyclonal antibodies, radial immunodiffusion kits and conjugated immunoglobulin fractions for manufacturers, universities and l...

More Information about "Ranbaxy Laboratories Ltd." on BioPortfolio

We have published hundreds of Ranbaxy Laboratories Ltd. news stories on BioPortfolio along with dozens of Ranbaxy Laboratories Ltd. Clinical Trials and PubMed Articles about Ranbaxy Laboratories Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ranbaxy Laboratories Ltd. Companies in our database. You can also find out about relevant Ranbaxy Laboratories Ltd. Drugs and Medications on this site too.


Advertisement
 

Relevant Topics

Generics Drugs
Latest News Clinical Trials Research Drugs Reports Corporate
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...

Healthcare
Latest News Clinical Trials Research Drugs Reports Corporate
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Drug Discovery
Latest News Clinical Trials Research Drugs Reports Corporate
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record